The information highlighted (if any) are the most recent updates for this brand.
Tiotropium bromide + Olodaterol HCl (Spiolto Respimat) is indicated for the long term, once-daily maintenance treatment in patients with COPD (including chronic bronchitis and emphysema), to reduce airflow obstruction, to improve quality of life, to reduce associated dyspnoea, to improve exercise tolerance and to reduce exacerbations.